Nymox Pharmaceutical Corporation (NYMX) Announces Lead Drug in Development Shows Positive Results

Nymox Pharmaceutical Corporation (Nasdaq: NYMX) claimed that NX-1207,produces strongly positive results when given to animals with hepatocellular carcinoma (HCC). In the experimental studies, the cancers were significantly reduced in size after 2 local injections of NX-1207.